Evidence map›Paper›PMID 23564622›Full record

ArticleThe International journal of biological markers2013

Plasma leptin levels, LEPR Q223R polymorphism and mammographic breast density: a cross-sectional study.

Cher Dallal, Seymour Garte, Camille Ragin, Jiangying Chen, Stacy Lloyd, Francesmary Modugno, Joel Weissfeld, Emanuela Taioli

Open access · greenAbstract read
In one paragraph

Article in The International journal of biological markers, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Genetic architecture of mammographic density as a risk factor for breast cancer: a systematic review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Cher DallalUniversity of Pittsburgh, Department of Epidemiology, Graduate School of Public Health, Pittsburgh, PA, USA.
Seymour Garte
Camille Ragin
Jiangying Chen
Stacy Lloyd
Francesmary Modugno
Joel Weissfeld
Emanuela Taioli
University of Pittsburgh · USFox Chase Cancer Center · USHofstra University · US

Funding

WITHIN SUBJ VARIABILITY IN MEASUREMENTS DRUG METABOL ENZYMES IN HLTY SUBJM01RR000056 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEVINE, ARTHUR S · 1985 to 2006
$29.2M
EDUCATION PROGRAMS IN CANCER PREVENTIONR25CA057703 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WEISSFELD, JOEL L · 1992 to 2010
$2.1M
Priority StageP20CA132385 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SOBOL, ROBERT W · 2007 to 2009
$465k
NCI NIH HHS P20 CA132385NCI NIH HHS P20 CA 132385-01NCI NIH HHS R25 CA057703NCI NIH HHS R25 CA57703NCRR NIH HHS M01 RR000056NCRR NIH HHS M01-RR000056
6 · The paper itself

Abstract

Obesity is associated with breast cancer in post-menopausal women, and breast density is a marker of breast cancer risk. Leptin is produced by the adipose tissue, acts through receptors that are polymorphic in nature, and is considered a cancer growth factor. The relationship between body mass index, leptin, leptin receptors and breast density is not well studied. A cross-sectional analysis in 392 post-menopausal healthy women was conducted; participants provided permission to obtain copies of their most recent screening mammogram. Non-fasting plasma leptin levels were determined using a commercially available leptin ELISA kit. Analysis of the Q223R genotypes of the LEPR gene were performed by PCR followed by restriction fragment length polymorphism analysis using DNA extracted from buffy coat samples. A statistically significant positive relationship was observed between leptin levels and body mass index (p<0.0001); leptin was significantly positively associated with mammography total breast area and non-dense breast area (p<0.0001), while it was inversely associated with percent breast density (p<0.0001). Leptin levels varied across the LEPR Q223R polymorphism, and were higher in women homozygous for the AA variant. Percent breast density decreased across the LEPR Q223R genotype, with lower percent density in women with the AA genotype. When dense area was considered according to quartiles of leptin and stratified by LEPR Q223R, a significant inverse trend between leptin levels and dense breast area was observed only among women with the G/G genotype (p-trend<0.001). After adjustment for possible confounders, leptin levels were significantly inversely associated with percent breast density (p=0.01). A significant interaction between body mass index and leptin levels on percent breast density was observed (p=0.03). These findings suggest that the association between leptin and breast density may vary by LEPR Q223R genotype, and that body mass index and leptin may act in an interactive way in determining breast density.

Indexed as

AdultAgedBiomarkers, TumorBreast DensityBreast NeoplasmsCross-Sectional StudiesEarly Detection of CancerFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansLeptinMammary Glands, HumanMiddle AgedPolymorphism, Single NucleotideBiomarkers, TumorLEPR protein, humanLeptinReceptors, Leptin

Identifiers

PMID23564622
PMCPMC4489688
OpenAlexW2087044021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.